These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

312 related items for PubMed ID: 29215813

  • 1. Kidney Transplantation in Patients with Atypical Hemolytic Uremic Syndrome due to Complement Factor H Deficiency: Impact of Liver Transplantation.
    Kim S, Park E, Min SI, Yi NJ, Ha J, Ha IS, Cheong HI, Kang HG.
    J Korean Med Sci; 2018 Jan 01; 33(1):e4. PubMed ID: 29215813
    [Abstract] [Full Text] [Related]

  • 2. Use of eculizumab and plasma exchange in successful combined liver-kidney transplantation in a case of atypical HUS associated with complement factor H mutation.
    Tran H, Chaudhuri A, Concepcion W, Grimm PC.
    Pediatr Nephrol; 2014 Mar 01; 29(3):477-80. PubMed ID: 24221349
    [Abstract] [Full Text] [Related]

  • 3. Favorable long-term outcomes of isolated liver transplantation in a child with atypical hemolytic uremic syndrome caused by a novel complement factor H mutation
.
    Cho H, Lee Y.
    Clin Nephrol; 2017 Jul 01; 88(1):52-56. PubMed ID: 28502324
    [Abstract] [Full Text] [Related]

  • 4. Tailored eculizumab therapy in the management of complement factor H-mediated atypical hemolytic uremic syndrome in an adult kidney transplant recipient: a case report.
    Xie L, Nester CM, Reed AI, Zhang Y, Smith RJ, Thomas CP.
    Transplant Proc; 2012 Dec 01; 44(10):3037-40. PubMed ID: 23195022
    [Abstract] [Full Text] [Related]

  • 5. Long-term successful liver-kidney transplantation in a child with atypical hemolytic uremic syndrome caused by homozygous factor H deficiency.
    Gonzales E, Ulinski T, Habes D, Deschênes G, Frémeaux-Bacchi V, Bensman A.
    Pediatr Nephrol; 2016 Dec 01; 31(12):2375-2378. PubMed ID: 27744619
    [Abstract] [Full Text] [Related]

  • 6. Liver transplantation for aHUS: still needed in the eculizumab era?
    Coppo R, Bonaudo R, Peruzzi RL, Amore A, Brunati A, Romagnoli R, Salizzoni M, Galbusera M, Gotti E, Daina E, Noris M, Remuzzi G.
    Pediatr Nephrol; 2016 May 01; 31(5):759-68. PubMed ID: 26604087
    [Abstract] [Full Text] [Related]

  • 7. Successful 7-Year Eculizumab Treatment of Plasmapheresis-Resistant Recurrent Atypical Hemolytic-Uremic Syndrome due to Complement Factor H Hybrid Gene: A Case Report.
    Vondrák K, Seeman T.
    Transplant Proc; 2018 Apr 01; 50(3):967-970. PubMed ID: 29661469
    [Abstract] [Full Text] [Related]

  • 8. Living Donor Kidney Transplantation in Atypical Hemolytic Uremic Syndrome: A Case Series.
    Duineveld C, Verhave JC, Berger SP, van de Kar NCAJ, Wetzels JFM.
    Am J Kidney Dis; 2017 Dec 01; 70(6):770-777. PubMed ID: 28821363
    [Abstract] [Full Text] [Related]

  • 9. Atypical hemolytic uremic syndrome recurrence after kidney transplantation.
    Matar D, Naqvi F, Racusen LC, Carter-Monroe N, Montgomery RA, Alachkar N.
    Transplantation; 2014 Dec 15; 98(11):1205-12. PubMed ID: 24933457
    [Abstract] [Full Text] [Related]

  • 10. Novel C3 mutation p.Lys65Gln in aHUS affects complement factor H binding.
    Volokhina E, Westra D, Xue X, Gros P, van de Kar N, van den Heuvel L.
    Pediatr Nephrol; 2012 Sep 15; 27(9):1519-24. PubMed ID: 22669319
    [Abstract] [Full Text] [Related]

  • 11. Distal Angiopathy and Atypical Hemolytic Uremic Syndrome: Clinical and Functional Properties of an Anti-Factor H IgAλ Antibody.
    Rigothier C, Delmas Y, Roumenina LT, Contin-Bordes C, Lepreux S, Bridoux F, Goujon JM, Bachelet T, Touchard G, Frémeaux-Bacchi V, Combe C.
    Am J Kidney Dis; 2015 Aug 15; 66(2):331-6. PubMed ID: 26015278
    [Abstract] [Full Text] [Related]

  • 12. Relative role of genetic complement abnormalities in sporadic and familial aHUS and their impact on clinical phenotype.
    Noris M, Caprioli J, Bresin E, Mossali C, Pianetti G, Gamba S, Daina E, Fenili C, Castelletti F, Sorosina A, Piras R, Donadelli R, Maranta R, van der Meer I, Conway EM, Zipfel PF, Goodship TH, Remuzzi G.
    Clin J Am Soc Nephrol; 2010 Oct 15; 5(10):1844-59. PubMed ID: 20595690
    [Abstract] [Full Text] [Related]

  • 13. Genetics and outcome of atypical hemolytic-uremic syndrome in Turkish children: a retrospective study between 2010 and 2017, a single-center experience.
    Conkar S, Mir S, Berdeli A.
    Iran J Kidney Dis; 2019 Sep 15; 13(5):316-321. PubMed ID: 31705748
    [Abstract] [Full Text] [Related]

  • 14. [Atypical hemolytic-uremic syndrome related to abnormalities within the complement system].
    Frémeaux-Bacchi V, Fakhouri F, Roumenina L, Dragon-Durey MA, Loirat C.
    Rev Med Interne; 2011 Apr 15; 32(4):232-40. PubMed ID: 21376430
    [Abstract] [Full Text] [Related]

  • 15. Overactivation of Complement Alternative Pathway in Postpartum Atypical Hemolytic Uremic Syndrome Patients with Renal Involvement.
    Song D, Yu XJ, Wang FM, Xu BN, He YD, Chen Q, Wang SX, Yu F, Song WC, Zhao MH.
    Am J Reprod Immunol; 2015 Oct 15; 74(4):345-56. PubMed ID: 26011580
    [Abstract] [Full Text] [Related]

  • 16. Haemolytic uraemic syndrome caused by factor H mutation: is single kidney transplantation under intensive plasmatherapy an option?
    Hirt-Minkowski P, Schaub S, Mayr M, Schifferli JA, Dickenmann M, Frémeaux-Bacchi V, Steiger J.
    Nephrol Dial Transplant; 2009 Nov 15; 24(11):3548-51. PubMed ID: 19633317
    [Abstract] [Full Text] [Related]

  • 17. Atypical hemolytic uremic syndrome diagnosed four years after ABO-incompatible kidney transplantation.
    Kawaguchi K, Kawanishi K, Sato M, Itabashi M, Fujii A, Kanetsuna Y, Huchinoue S, Ohashi R, Koike J, Honda K, Nagashima Y, Nitta K.
    Nephrology (Carlton); 2015 Jul 15; 20 Suppl 2():61-5. PubMed ID: 26031589
    [Abstract] [Full Text] [Related]

  • 18. Complement factor H, FHR-3 and FHR-1 variants associate in an extended haplotype conferring increased risk of atypical hemolytic uremic syndrome.
    Bernabéu-Herrero ME, Jiménez-Alcázar M, Anter J, Pinto S, Sánchez Chinchilla D, Garrido S, López-Trascasa M, Rodríguez de Córdoba S, Sánchez-Corral P.
    Mol Immunol; 2015 Oct 15; 67(2 Pt B):276-86. PubMed ID: 26163426
    [Abstract] [Full Text] [Related]

  • 19. CFH and CFHR structural variants in atypical Hemolytic Uremic Syndrome: Prevalence, genomic characterization and impact on outcome.
    Piras R, Valoti E, Alberti M, Bresin E, Mele C, Breno M, Liguori L, Donadelli R, Rigoldi M, Benigni A, Remuzzi G, Noris M.
    Front Immunol; 2022 Oct 15; 13():1011580. PubMed ID: 36793547
    [Abstract] [Full Text] [Related]

  • 20. A novel atypical hemolytic uremic syndrome-associated hybrid CFHR1/CFH gene encoding a fusion protein that antagonizes factor H-dependent complement regulation.
    Valoti E, Alberti M, Tortajada A, Garcia-Fernandez J, Gastoldi S, Besso L, Bresin E, Remuzzi G, Rodriguez de Cordoba S, Noris M.
    J Am Soc Nephrol; 2015 Jan 15; 26(1):209-19. PubMed ID: 24904082
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.